NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for immunogen


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response
2009 NOV 23 ... storm, such as tumor necrosis factor alpha or interleukin 1. Immunization with a LEAPS-immunogen for herpes simplex virus activates a protective T cell immune response against the virus ...
Subject: Herpes Simplex
Price: $3.00
*
Data from Children's Hospital advance knowledge in gene therapy
2009 SEP 21 ... "The key to an effective HIV vaccine is development of an immunogen that elicits persisting antibodies with broad neutralizing activity against field ...
Subject: Gene Therapy
Price: $3.00
*
Data on cancer vaccines detailed by researchers at University of Maryland
2009 AUG 24 ... No serious adverse events were observed. PSA: 154-163 (155L) is not an effective immunogen when given with Montanide ISA-51," wrote D.V. Kouiavskaia and colleagues, University of ...
Subject: Cancer Vaccines
Price: $3.00
*
Data on immunization published by researchers at State University of New York
2009 OCT 5 ... surface proteins, and lipooligosaccharides (LOS) and detoxified LOS may be an effective immunogen in mice. In this study, we used a specific LOS-based enzyme-linked immunosorbent assay ...
Subject: Immunization
View Free
Daily News
Article
Findings from C.R. Chen and co-researchers advance knowledge in bioengineering
2009 SEP 7 ... CS-17 recognition. No mutation affected TSH-stimulated cAMP generation. Because the immunogen for CS-17 generation was highly glycosylated, we also investigated whether the glycan ...
Subject: Bioengineering
Price: $3.00
*
ImmunoGen, Inc. Announces Election of Howard Pien to its Board of Directors and Other Results from its Annual Meeting of Shareholders
2009 NOV 23 ... ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer ...
Subject: ImmunoGen, Inc.
Price: $3.00
*
ImmunoGen, Inc. Reports First Quarter Fiscal Year 2010 Financial Results
2009 NOV 9 ... ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products ...
Subject: ImmunoGen, Inc.
Price: $3.00
*
Investigators at Sankyo Co., Ltd. have published new data on monoclonal antibodies
2009 NOV 9 ... in monkey blood might contribute to an increase in its chances of being recognized as an immunogen." Saitoyabe and colleagues published the results of their research in ...
Subject: Monoclonal Antibodies
View Free
Daily News
Article
Research from Central South University in the area of immunization published
2009 NOV 9 ... study in Neurochemical Research (Intramembranous Fragment of Amyloid-beta: A Potential Immunogen for Alzheimer's Disease Immunotherapy. Neurochemical Research, 2009;34(11):1889-1895). ...
Subject: Immunization
Price: $3.00
*
Research from University of Oxford provides new data on HIV/AIDS
2009 SEP 28 ... for HLA-B*5101(+) patients infected with HIV-1 clade B. These vaccines employ novel immunogen HIVB-B*5101 derived from consensus HIV-1 clade B Gag p17 and p24 regions coupled to two ...
Subject: HIV/AIDS
Price: $3.00
*
Research in the area of hepatitis C virus reported from University of Strasbourg
2009 OCT 12 ... vaccine GI-5005, being developed by GlobeImmune Inc, is a Tarmogen (targeted molecular immunogen) consisting of recombinant Saccharomyces cerevisiae yeast expressing an HCV NS3-core ...
Subject: Hepatitis C Virus
Price: $3.00
*
Research on HIV/AIDS detailed by A.J. Hessell and co-authors
2009 AUG 17 ... According to a study from the United States, "Developing an immunogen that elicits broadly neutralizing antibodies (bNAbs) is an elusive but important goal of ...
Subject: HIV/AIDS
Price: $3.00
*
Researchers from Anna University publish new studies and findings in the area of DNA vaccines
2009 SEP 21 ... analysis of the humoral and cellular immune responses indicated that BmTGA is a potent immunogen. However, protection studies as determined by the micropore chamber method using live ...
Subject: DNA Vaccines
Price: $3.00
*
Researchers from Shahrekord University of Medical Sciences, Department of Parasitology report recent findings in protease
2009 SEP 28 ... serine protease of Schistosoma mansoni larvae, the cercarial elastase (CE), was a poor immunogen in as much as it failed to induce an antibody response. The CE has a critical role in ...
Subject: Protease
Price: $3.00
*
Studies from Emory University, Medical Department update current data on alloimmunization
2009 SEP 21 ... murine cytomegalovirus expressing mHEL (mHEL-MCMV) was used as a control non-RBC immunogen. Humoral responses were measured by mHEL-specific enzyme-linked immunosorbent assay and ...
Subject: Alloimmunization
Price: $3.00
*
Studies in the area of biotechnology business reported from ImmunoGen, Inc.
2009 NOV 2 ... leading to the difference in the results," wrote C.T. Huang and colleagues, ImmunoGen, Inc. The researchers concluded: "Imaging-based technologies could aid in ...
Subject: Biotechnology Business
View Free
Daily News
Article
Study data from University of Kansas update knowledge of HIV/AIDS
2009 NOV 2 ... mannose glycans; these features mimic the glycosylation profile of a Group M consensus immunogen, CON-S. Our results also reveal a clade-specific glycosylation pattern," wrote E.P. Go ...
Subject: HIV/AIDS
Price: $3.00
*
Study findings from D. Mcilroy et al provide new insights into immunization
2009 OCT 12 ... vaccination using a beta-galactosidase (beta Gal) encoding plasmid, pCMV-beta Gal, as immunogen." "At a high DNA dose, formulation with the tetrafunctional block ...
Subject: Immunization
Price: $3.00
*
Third Military Medical University publishes research in vaccines
2009 OCT 12 ... fragment (stx2a(1)) of the shiga-like toxin 2A (1) subunit of EHEC O157:H7: candidate immunogen for a subunit vaccine' have been presented. According to recent research from ...
Subject: Vaccines
View Free
Daily News
Article
University of Bern reports research in vaccines
2009 NOV 1 ... of adult horses elicited robust serum antibody response in an ELISA using the immunogen as a capture antigen. Immune sera showed dose-dependent high potency in neutralizing ...
Subject: Vaccines
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login